Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial - Wikidata - wikimedia - TriplyDB

Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial

Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial

http://www.wikidata.org/entity/Q36837106

about

Short- and long-term reproducibility of marrow adipose tissue quantification by 1H-MR spectroscopy Effects of growth hormone administration for 6 months on bone turnover and bone marrow fat in obese premenopausal women The Role of the Growth Hormone/Insulin-Like Growth Factor System in Visceral Adiposity.Assessment of intramuscular lipid and metabolites of the lower leg using magnetic resonance spectroscopy in boys with Duchenne muscular dystrophy.Effects of recombinant human growth hormone (rhGH) administration on body composition and cardiovascular risk factors in obese adolescent girls.Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies.Effects of growth hormone withdrawal in obese premenopausal women Effect of growth hormone on cognitive function in young women with abdominal obesity.Association between adiposity and cognitive function in young men: Hormonal mechanisms Vertebral Strength and Estimated Fracture Risk Across the BMI Spectrum in Women.Assessment of abdominal fat compartments using DXA in premenopausal women from anorexia nervosa to morbid obesity.Metabolic and endocrine correlates of cognitive function in healthy young women Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity Growth hormone receptor expression in human gluteal versus abdominal subcutaneous adipose tissue: Association with body shape The Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver Disease The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations.Peripheral targets in obesity treatment: a comprehensive update.Maternal obesity programs reduced leptin signaling in the pituitary and altered GH/IGF1 axis function leading to increased adiposity in adult sheep offspring.What Can We Learn from Interventions That Change Fat Distribution?Short- and Long-Term Reproducibility of Intrahepatic Lipid Quantification by 1H-MR Spectroscopy and CT in Obesity.Growth Hormone's Effect on Adipose Tissue: Quality versus Quantity.GH administration decreases subcutaneous abdominal adipocyte size in men with abdominal obesity.Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency.Sex differences in body composition and association with cardiometabolic risk.

P2860

Q31022591-6BE01AAA-BA07-4F65-BAEE-EBA98B5FDD0D Q33582815-EAC43AB0-3F09-4DE1-B9BF-0D842F77629F Q33602919-004D3184-552D-4C24-8CCB-8ABCED094F45 Q34081572-7654F3C2-A692-4A66-897C-DABE5B539409 Q34584665-66C28886-ACF2-4A76-8AA4-48B8A38592A1 Q35072510-5B996A38-42B0-4C98-A070-B28243E9E822 Q36652243-ACB31EF4-1DBE-4F31-906F-0FDCF8A1B4C7 Q36680067-8C3C92E6-93D8-44DD-962C-61705F1D1032 Q36746546-AFABA918-CB45-4312-91A6-6BA8528E7FF3 Q36804465-C20BEF82-B0E5-4372-A85D-9176267E2475 Q36948294-7FF9D946-0A35-45E8-A7A6-78CCBBC4C49E Q37092852-9B710529-7A25-4A11-92D0-15920811FC23 Q37149597-94188102-3B94-440D-AE20-B3BA93CE0069 Q37252101-E0140A81-5EC5-4BB6-9CA9-6018788E4195 Q37374694-7B74EE5E-8363-4A6F-84B6-922A4BA38E2F Q37620363-AFF36719-3F19-4EB6-B943-581EAF0CED8D Q38097351-0CBECBC1-66B9-4CAE-B751-2EC05D1CC0FD Q38194649-03289E5B-25D1-4A43-AEFE-E98E35D3DD48 Q38644465-31E22606-5E59-4E17-92FE-C1191793AB70 Q38801156-9D7BBCB8-DCD7-462B-A51A-3B0251C462A5 Q41104879-5AE89CDE-6810-400D-A17A-AF210F807D3C Q41573026-686C9833-9352-4626-9E7D-D213DFF3D7D3 Q47205220-4C3C794B-DC72-4224-89F9-55A9F860EEA8 Q53698784-B50ACC11-2861-403B-8F02-486820E80F6E Q55513980-B3009E4F-4622-4DF8-BFB5-60F136958AE0

P2860

Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial

http://www.wikidata.org/entity/Q36837106

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Effects of GH in women with ab ...... lind, placebo-controlled trial

@en

type

label

Effects of GH in women with ab ...... lind, placebo-controlled trial

@en

prefLabel

Effects of GH in women with ab ...... lind, placebo-controlled trial

@en

P1433

Q36837106-87F7DB09-BF8B-4FA0-BD5B-7C8DB0692025

P1476

Q36837106-ADFF2D75-57F6-47A1-B5DD-E3A495F7A900

P2093

Q36837106-15472A6C-D172-4FE2-9050-D69F35F33A9E

Q36837106-1D495420-012D-4B4E-9028-49E700BDD9CB

Q36837106-1F82EFE7-C7CA-45BA-A136-F75AE64477A5

Q36837106-243F88DA-5A2E-4E53-8D5A-5D1AA8B9A689

Q36837106-2822DFD1-7BF9-4613-8BF8-9E5CAD8506EE

Q36837106-4D5E5817-B07C-4FEF-B4E8-977F8FBC7BAB

Q36837106-72F8D909-BF33-4800-87AE-4D3079B0AD39

Q36837106-74A0DF7A-DC6B-4025-B09C-F43EA9FDA78C

Q36837106-7A04167B-7987-4842-9C88-C2358F256926

Q36837106-A8ADEE70-7FDF-45E0-AE31-8CA9D5AA3745

P2860

Q36837106-0778DF5F-3C1C-4F78-86AD-59ECDD256E15

Q36837106-0BEE4825-1DD7-4278-B840-F75C4652144E

Q36837106-0D188A45-5716-4050-8BEE-342AAC9CD6E8

Q36837106-0EE34CD9-459C-4C20-AA06-555793124705

Q36837106-1E486A4C-ABFF-4CA7-BF5F-AF0F3E4ECAB6

Q36837106-1E5BFB06-38D6-4F2B-AC2D-990063AD8440

Q36837106-2DBE9F5B-794D-466F-B368-A241E8E6243D

Q36837106-2F5B19A1-4589-4F25-AE7F-DD1CBF356497

Q36837106-342E80B9-985D-4248-A9E4-3B6D14C6FB32

Q36837106-3C793379-56F9-4C2D-B835-79B4E580CECF

P304

Q36837106-FD5DBAA4-5729-485D-A60F-DB59A82836F4

P31

Q36837106-8DEC2AA8-8998-4FAF-A269-90132B672D00

P356

Q36837106-FCDD713F-A036-4E44-A4B9-E223581C1BFC

P433

Q36837106-C85A8947-9A02-40AE-90E5-4D8B94F306DC

P478

Q36837106-6E9A8BD9-0FF5-4111-A887-7B775B7B8A07

P577

Q36837106-B9AA2072-C352-4F8C-AA90-7DF405D4FAD9

P698

Q36837106-6617F968-34E6-4E68-A3CF-B5F0986CE449

P921

Q36837106-0D23059B-C739-40D5-9004-268383B56C85

P932

Q36837106-C49FAC91-9931-47EF-AE63-5201C05A82CE

P356

P1433

European Journal of Endocrinology

P1476

Effects of GH in women with ab ...... lind, placebo-controlled trial

@en

P2093

Andrea L Utz

http://www.w3.org/2001/XMLSchema#string

Anne Breggia

http://www.w3.org/2001/XMLSchema#string

Anu V Gerweck

http://www.w3.org/2001/XMLSchema#string

Bijoy J Thomas

http://www.w3.org/2001/XMLSchema#string

Clifford J Rosen

http://www.w3.org/2001/XMLSchema#string

Danielle J Brick

http://www.w3.org/2001/XMLSchema#string

David A Schoenfeld

http://www.w3.org/2001/XMLSchema#string

Eleanor Lin

http://www.w3.org/2001/XMLSchema#string

Karen K Miller

http://www.w3.org/2001/XMLSchema#string

Linda C Hemphill

http://www.w3.org/2001/XMLSchema#string

P2860

Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement.

Treatment of obesity: need to focus on high risk abdominally obese patients.

Breath-hold 1H-magnetic resonance spectroscopy for intrahepatic lipid quantification at 3 Tesla

Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample

Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women.

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study.

Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials.

Loss of resistance to dietary cholesterol in the rat after hypophysectomy: importance of the presence of growth hormone for hepatic low density lipoprotein-receptor expression.

Comparison of DXA and CT in the assessment of body composition in premenopausal women with obesity and anorexia nervosa.

P304

601-611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/EJE-11-1068

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

166

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22275471

http://www.w3.org/2001/XMLSchema#string

P921

P932

3651853

http://www.w3.org/2001/XMLSchema#string